Zota Health Care Acquires 2.35 Lakh Shares in Subsidiary Davaindia Health Mart
Zota Health Care Limited acquired 2,35,512 equity shares in its subsidiary, Davaindia Health Mart Limited, on July 17, 2026. The acquisition, valued at ₹1,195.22 crore, was a conversion of outstanding unsecured loans. Davaindia Health Mart reported FY26 turnover of ₹267.71 crore. This move aims to reduce consolidated debt and improve net worth.
The acquisition of a wholly-owned subsidiary through debt conversion is a significant internal restructuring that can impact the group's financial health, justifying a medium impact.
The acquisition is positive as it involves converting debt into equity, reducing the group's overall debt and improving its net worth. The subsidiary also shows significant revenue growth.
Zota Health Care Limited has announced the acquisition of 2,35,512 equity shares in its wholly-owned subsidiary, Davaindia Health Mart Limited. This acquisition was made on a preferential basis, not for cash, but as an adjustment and discharge of an outstanding unsecured loan, including accumulated interest, previously granted by Zota Health Care to Davaindia Health Mart.
Davaindia Health Mart Limited operates a retail generic pharmacy chain under the COCO model. As of the audited financial statements for FY 2025-26, the subsidiary reported a turnover of ₹267.71 crore and a total paid-up share capital of ₹2.71 crore. The company was incorporated on January 1, 2020, and as of June 30, 2026, it operated 1,855 COCO stores, offering over 2,000 SKUs. The turnover for FY 2024-25 was ₹109.93 crore, and for FY 2023-24, it was ₹44.77 crore.
The acquisition, valued at ₹1,19,52,23,400, was completed on July 17, 2026. The cost of acquisition for each equity share was ₹5,075, including a premium of ₹5,065. This transaction is considered an arm's length transaction and does not fall within related party transactions. The stated objective of this investment is to reduce the group's total outstanding debt on a consolidated basis and improve the group's overall net worth. Following the acquisition, Davaindia Health Mart Limited continues to be a wholly-owned subsidiary of Zota Health Care Limited.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.